Jacqueline Ramke1, Anthony B Zwi1, Anna Palagyi2, Ilse Blignault3, Clare E Gilbert4. 1. a University of New South Wales, School of Social Sciences, Faculty of Arts and Social Sciences , Sydney , New South Wales , Australia . 2. b The George Institute for Global Health, Sydney Medical School, University of Sydney , Sydney , New South Wales , Australia . 3. c University of New South Wales, School of Public Health and Community Medicine , Sydney , New South Wales , Australia , and. 4. d London School of Hygiene & Tropical Medicine, Clinical Research Unit, Department of Infectious and Tropical Diseases , London , UK.
Abstract
PURPOSE: The World Health Organization Program for the Prevention of Blindness adopted the principles of universal health coverage (UHC) in its latest plan, Universal Eye Health: A Global Action Plan, 2014-2019. This plan builds on the achievements of Vision 2020, which aimed to reduce the global prevalence of avoidable blindness, and its unequal distribution, by the year 2020. METHODS: We reviewed the literature on health equity and the generation and use of evidence to promote equity, particularly in eye health. We describe the nature and extent of the equity-focused evidence to support and inform eye health programs on the path to universal eye health, and propose ways to improve the collection and reporting of this evidence. RESULTS: Blindness prevalence decreased in all regions of the world between 1990 and 2010, albeit not at the same rate or to the same extent. In 2010, the prevalence of blindness in West Africa (6.0%) remained 15 times higher than in high-income regions (0.4%); within all regions, women had a higher prevalence of blindness than men. Beyond inter-regional and sex differences, there is little comparable data on the distribution of blindness across social groups within regions and countries, or on whether this distribution has changed over time. Similarly, interventions known to address inequity in blindness are few, and equity-relevant goals, targets and indicators for eye health programs are scarce. CONCLUSION: Equity aims of eye health programs can benefit from the global momentum towards achieving UHC, and the progress being made on collecting, communicating and using equity-focused evidence.
PURPOSE: The World Health Organization Program for the Prevention of Blindness adopted the principles of universal health coverage (UHC) in its latest plan, Universal Eye Health: A Global Action Plan, 2014-2019. This plan builds on the achievements of Vision 2020, which aimed to reduce the global prevalence of avoidable blindness, and its unequal distribution, by the year 2020. METHODS: We reviewed the literature on health equity and the generation and use of evidence to promote equity, particularly in eye health. We describe the nature and extent of the equity-focused evidence to support and inform eye health programs on the path to universal eye health, and propose ways to improve the collection and reporting of this evidence. RESULTS:Blindness prevalence decreased in all regions of the world between 1990 and 2010, albeit not at the same rate or to the same extent. In 2010, the prevalence of blindness in West Africa (6.0%) remained 15 times higher than in high-income regions (0.4%); within all regions, women had a higher prevalence of blindness than men. Beyond inter-regional and sex differences, there is little comparable data on the distribution of blindness across social groups within regions and countries, or on whether this distribution has changed over time. Similarly, interventions known to address inequity in blindness are few, and equity-relevant goals, targets and indicators for eye health programs are scarce. CONCLUSION: Equity aims of eye health programs can benefit from the global momentum towards achieving UHC, and the progress being made on collecting, communicating and using equity-focused evidence.
Entities:
Keywords:
Blindness; Vision 2020; evidence; health equity; low and middle income countries; universal eye health
Authors: M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger Journal: Ophthalmologe Date: 2019-02 Impact factor: 1.059
Authors: Nyawira Mwangi; Covadonga Bascaran; Mark Ng'ang'a; Jacqueline Ramke; Mathew Kipturgo; Stephen Gichuhi; Min Kim; David Macleod; Consuela Moorman; David Muraguri; Esbon Gakuo; Lawrence Muthami; Allen Foster Journal: Pilot Feasibility Stud Date: 2020-07-16
Authors: Danba Jiachu; Feng Jiang; Li Luo; Hong Zheng; Ji Duo; Jing Yang; Yongcuo Nima; Jin Ling; Baixiang Xiao; Ken Bassett Journal: BMJ Open Ophthalmol Date: 2018-11-17
Authors: Rivka R Lilian; Jean Railton; Erik Schaftenaar; Moyahabo Mabitsi; Cornelis J Grobbelaar; N Sellina Khosa; Babra H Maluleke; Helen E Struthers; James A McIntyre; Remco P H Peters Journal: PLoS One Date: 2018-05-14 Impact factor: 3.240
Authors: Jacqueline Ramke; Anthony B Zwi; Juan Carlos Silva; Nyawira Mwangi; Hillary Rono; Michael Gichangi; Muhammad Babar Qureshi; Clare E Gilbert Journal: Bull World Health Organ Date: 2018-08-27 Impact factor: 9.408